Literature DB >> 17222479

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages.

Amitabha Majumdar1, Haeyong Chung, Georgia Dolios, Rong Wang, Nikiya Asamoah, Peter Lobel, Frederick R Maxfield.   

Abstract

Cultured microglia internalize fibrillar amyloid Abeta (fAbeta) and deliver it to lysosomes. Degradation of fAbeta by microglia is incomplete, but macrophages degrade fAbeta efficiently. When mannose-6 phosphorylated lysosomal enzymes were added to the culture medium of microglia, degradation of fAbeta was increased, and the increased degradation was inhibited by excess mannose-6-phosphate, which competes for binding and endocytic uptake. This suggests that low activity of one or more lysosomal enzymes in the microglia was responsible for the poor degradation of fAbeta. To further characterize the degradation of fAbeta in late endosomes and lysosomes, we analyzed fAbeta-derived intracellular degradation products in macrophages and microglia by mass spectrometry. Fragments with truncations in the first 12 N-terminal residues were observed in extracts from both cell types. We also analyzed material released by the cells. Microglia released mainly intact Abeta1-42, whereas macrophages released a variety of N-terminal truncated fragments. These results indicate that initial proteolysis near the N-terminus is similar in both cell types, but microglia are limited in their ability to make further cuts in the fAbeta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222479      PMCID: PMC2424018          DOI: 10.1016/j.neurobiolaging.2006.12.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  35 in total

1.  Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

Authors:  B J Bacskai; S T Kajdasz; R H Christie; C Carter; D Games; P Seubert; D Schenk; B T Hyman
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

2.  [Microglia: origin and development].

Authors:  B Pessac; I Godin; F Alliot
Journal:  Bull Acad Natl Med       Date:  2001       Impact factor: 0.144

3.  The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity.

Authors:  S W Sakr; R J Eddy; H Barth; F Wang; S Greenberg; F R Maxfield; I Tabas
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

4.  Structural features of the Abeta amyloid fibril elucidated by limited proteolysis.

Authors:  I Kheterpal; A Williams; C Murphy; B Bledsoe; R Wetzel
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

5.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

6.  Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Authors:  Axel Nimmerjahn; Frank Kirchhoff; Fritjof Helmchen
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

7.  Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.

Authors:  L Lin; P Lobel
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

8.  Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

Authors:  H Chung; M I Brazil; T T Soe; F R Maxfield
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

9.  The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.

Authors:  J Wegiel; K C Wang; H Imaki; R Rubenstein; A Wronska; M Osuchowski; W J Lipinski; L C Walker; H LeVine
Journal:  Neurobiol Aging       Date:  2001 Jan-Feb       Impact factor: 4.673

Review 10.  Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease.

Authors:  J Rogers; L F Lue
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

View more
  39 in total

1.  Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

Authors:  Aaron Y Lai; Joanne McLaurin
Journal:  Future Neurol       Date:  2012-03-01

2.  Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.

Authors:  Kalliopi Thanopoulou; Apostolia Fragkouli; Fotini Stylianopoulou; Spiros Georgopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

Review 3.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  Surface adsorption considerations when working with amyloid fibrils in multiwell plates and Eppendorf tubes.

Authors:  Amber N Murray; Fernando L Palhano; Jan Bieschke; Jeffery W Kelly
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

Review 5.  Immune activation in brain aging and neurodegeneration: too much or too little?

Authors:  Kurt M Lucin; Tony Wyss-Coray
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 6.  Nuclear receptors as therapeutic targets for Alzheimer's disease.

Authors:  Shweta Mandrekar-Colucci; Gary E Landreth
Journal:  Expert Opin Ther Targets       Date:  2011-07-01       Impact factor: 6.902

7.  Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.

Authors:  Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Songlin Li; Vladimir Ljubimov; Michelle Moyseyev; David Daley; Dieu-Trang Fuchs; Michael Pham; Keith L Black; Altan Rentsendorj; Maya Koronyo-Hamaoui
Journal:  Brain       Date:  2015-06-06       Impact factor: 13.501

8.  Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome.

Authors:  Mi-Hyang Cho; Kwangmin Cho; Hoe-Jin Kang; Eun-Young Jeon; Hun-Sik Kim; Hyung-Joon Kwon; Hong-Mi Kim; Dong-Hou Kim; Seung-Yong Yoon
Journal:  Autophagy       Date:  2014-07-22       Impact factor: 16.016

Review 9.  Role of endosomes and lysosomes in human disease.

Authors:  Frederick R Maxfield
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-05-01       Impact factor: 10.005

10.  Staging anti-inflammatory therapy in Alzheimer's disease.

Authors:  Mathieu P Lichtenstein; Paulina Carriba; Roser Masgrau; Aurora Pujol; Elena Galea
Journal:  Front Aging Neurosci       Date:  2010-10-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.